Dyadic Yoga Program for Patients Undergoing Thoracic Radiotherapy and Their Family Caregivers: The Testing of a Mobile Application Delivery
The goal of the trial is to test the usability, feasibility and acceptability of an unsupervised, appbased yoga program for participants undergoing thoracic RT and their caregivers.
Checked against the public recordLast updated Jan 9, 2026 · Source: ClinicalTrials.gov
What this study is about
- Purpose
- Supportive Care
- Study type
- Interventional
- Phase
- Not applicable
- Sponsor
- M.D. Anderson Cancer Center
- Interventions being studied
- Behavioral: Thinking out Loud Session
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
Inclusion Criteria: 1. Be diagnosed with a non-small cell lung cancer or esophageal cancer and going to receive at least 24 fractions thoracic RT 2. Have an ECOG performance status of \<2 3. Have a family caregiver (e.g., spouse, sibling, adult child) willing to participate Both patient and caregiver must meet all the following criteria: 1. Be \>18 years old 2. Be able to read and speak English 3. Be able to provide informed consent 4. Have regular (self-defined) access to Wi-Fi/High speed internet access Exclusion Criteria: 1. Experiences cognitive deficits that would impede the completion of self-report instruments as deemed by their attending oncologist 2. Experiences contraindications to exercise as determined by the clinical team 3. Regularly (self-defined) participants in a yoga program in the year prior to diagnosis Participants who participated in part 1 are ineligible to participate in part 2 of this protocol.
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- The University of Texas M. D. Anderson Cancer CenterHouston, Texas
Source and freshness
Processed from ClinicalTrials.gov. Last public update: Jan 9, 2026. Always confirm current availability with the study team.